Navigation Links
Canada should significantly increase its funding of randomized clinical trials
Date:5/22/2012

Large randomized controlled trials (RCTs) are critical for determining effectiveness of medical therapies, tests and procedures. Yet Canada provides scant support for these studies compared with other western countries, states an analysis in CMAJ (Canadian Medical Association Journal).

Dr. Salim Yusuf, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, with Dr. John Cairns, University of British Columbia, argue in the analysis and appendix that Canada should provide better financial support of clinical trials and remove some of the bureaucratic and administrative barriers that are challenging to conducting trials in Canada.

It is critical to fund clinical trials in Canada, rather than relying on evidence from trials conducted in other countries. Countries that conduct RCTs are usually the first to experience the health benefits of the trials. As well, some studies must be conducted locally because of the unique social and health context. RCTs also provide economic stimulus and have led to successful industry spin offs.

Canada's major funding agency, the Canadian Institutes of Health Research (CIHR), provided about Can$1 billion in research funding in 2010/11, equivalent to Can$29 per capita or 0.07% of overall gross domestic product (GDP). This is significantly less than in the US, which provided Can$31 billion in 2010/11 US$100 per capita or 0.2% of the US GDP. The United Kingdom provides Can$3.2 billion, or Can$45 per capita expenditure, 0.12% of the UK GDP. In Canada and the US, provincial governments and health charities also provide additional funding.

The disparity between countries widens when one looks at specific funding for clinical trials. CIHR allocated only 3.3% of its budget (2009/10) to clinical trials, whereas the US National Institutes of Health spent 11% of its Can$31 billion total budget on clinical trials.

"The CIHR should sharply increase funding for peer review for clinical trials to more than 10% of its overall budget," write the authors. "This shift could happen within the next four to five years and grow to 15% of the total CIHR budget to ensure that the clinical relevance of discoveries from other forms of research can be rapidly assessed."

"Developing, enhancing and sustaining Canada's capacity to conduct world-class clinical studies will enable Canada to make important contributions that will improve health," the authors conclude.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Related medicine news :

1. Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
2. DTM Systems Corporation Ranked Number One as the Largest Reseller in British Columbia to Hewlett Packard Canada
3. Strategic Connections Ranks 90th Fastest-Growing Technology Company in North America and 14th in Canada
4. Canadian EMR Vendor Nightingale Exhibiting at Spring 2010 Canada Health Infoway Partnership Conference
5. Tax Return Appointment Fees to be Donated to Charity by Tax Team Canada
6. Canada joins international network providing free access to health research
7. AMD Global Telemedicine Inc. Chosen by InterHealth Canada as the Telemedicine Solutions Provider for Turks and Caicos Hospital Project
8. 'Winds of Change with Jivi' Breathes New Life to Daytime Talk Show Landscape in Canada
9. Muscle Building Expert Vince Del Monte Feeds the Hungry with a $5,000 Donation to the Hamilton Food Share in Canada
10. Survey highlights major Canada-US differences in people in middle age
11. Summertime Decadence: Rodelle Cocoa Launches in Western Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: